Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I just received the letter addresed to David Pohl from Ronran.

I previously apologized for being late to the table on this and would like those who do not have a genuine interest in this discussion to please have the courtesy to refrain from responding. I'm not into the personal crabbiness of what you may or may not want to read. I never complain about others OT topics and just pass them up. I would like the same consideration in my attempt (lame or not) to discuss PTSC.

 Regarding the warrant subject (in Ronran's letter), were there any answers given? Maybe that might explain the casual dismissive air about the subject I'm picking up. 

We might have a new CEO but the same cast and crew are on the BOD. I would think that their decisions and/or performance, past and present, should always be up for evaluation and be a continual process. It's just the way I personally evaluate companies.

Did S&L actually say there were going to hold the shares reported in the SC13G/A? Is that the common belief here on this board once the warrants are washed out? Just that stake alone is 3 1/2 times the 5.4 mil original loan at .50 per share and 3-6 more months to wash out. Gosh, I hope they hold'em for our sake. 

Please, only people with interest in this discussion or Ronran.

Share
New Message
Please login to post a reply